Zwerling Charles S MD is categorized under Optometrists in Goldsboro, NC and active since 2007.
Zwerling Charles S MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Optometrists business, which does work in the B2C market, and is classified as a Optometrists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Charles Zwerling at the company’s single location by writing to 2709 Medical Office Place, Goldsboro, North Carolina NC 27534 or by phoning (919) 736-3937. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Zwerling Charles S MD |
| Contact Person: | Charles Zwerling |
| Address: | 2709 Medical Office Place, Goldsboro, North Carolina 27534 |
| Phone Number: | (919) 736-3937 |
| Website Address: | goldsboroeyeclinic.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Optometrists |
| SIC Code: | 8042 |
| NAICS Code: | 6211110 |
| Share This Business: |
Zwerling Charles S MD was started in 2007 to provide professional Optometrists under the SIC code 8042 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Charles Zwerling for inquiries that concern Zwerling Charles S MD by calling the company number (919) 736-3937, as your correspondence is most welcome. Additionally, the physical location of the single location of Zwerling Charles S MD can be found at the coordinates 35.40216,-77.9516 as well as the street address 2709 Medical Office Place in Goldsboro, North Carolina 27534.
For its online presence, you may visit Zwerling Charles S MD’s website at goldsboroeyeclinic.com and engage with its social media outlets through on Twitter and on Facebook.